An Open Label Phase 2 Feasibility Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in Treatment of Moderate to Severe Papulopustular Rosacea (BPX-01-C05)

Trial Profile

An Open Label Phase 2 Feasibility Study to Assess the Safety and Efficacy of BPX-01 Minocycline Topical Gel in Treatment of Moderate to Severe Papulopustular Rosacea (BPX-01-C05)

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 21 Sep 2017

At a glance

  • Drugs Minocycline (Primary)
  • Indications Rosacea
  • Focus Therapeutic Use
  • Sponsors BioPharmX Corporation
  • Most Recent Events

    • 13 Sep 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.
    • 13 Sep 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Dec 2017.
    • 13 Sep 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top